59
Views
7
CrossRef citations to date
0
Altmetric
Original Research

Fondaparinux vs warfarin for the treatment of unsuspected pulmonary embolism in cancer patients

, , , , , , , , , , , & show all
Pages 2041-2046 | Published online: 23 Jun 2016

References

  • HeitJAO’FallonWMPettersonTMRelative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based studyArch Intern Med2002162111245124812038942
  • MonrealMFalgáCValdésMFatal pulmonary embolism and fatal bleeding in cancer patients with venous thromboembolism: findings from the RIETE registryJ Thromb Haemost2006491950195616961602
  • DoumaRAKokMGVerberneLMKamphuisenPWBüllerHRIncidental venous thromboembolism in cancer patients: prevalence and consequenceThromb Res20101256e306e30920223502
  • DentaliFAgenoWBecattiniCPrevalence and clinical history of incidental, asymptomatic pulmonary embolism: a meta-analysisThromb Res2010125651852220451960
  • BoswellWDPierceJFahimiAPariskyYShethPIncidental pulmonary emboli detected by multi-detector row spiral CT in cancer patientsCancer Imaging20055252616154815
  • BrowneAMCroninCGEnglishCNiMhuircheartaighJMurphyJMBruzziJFUnsuspected pulmonary emboli in oncology patients undergoing routine computed tomography imagingJ Thorac Oncol20105679880320421822
  • KearonCAklEAComerotaAJAmerican College of Chest PhysiciansAntithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelinesChest2012141suppl 2e419Se494S22315268
  • PalleriaCDi PaoloAGiofrèCPharmacokinetic drug-drug interaction and their implication in clinical managementJ Res Med Sci201318760161024516494
  • NobleSIFinlayIGIs long-term low-molecular-weight heparin acceptable to palliative care patients in the treatment of cancer related venous thromboembolism? A qualitative studyPalliat Med200519319720115920933
  • WeitzJILow-molecular-weight heparinsN Engl J Med1997337106886989278467
  • LeporiniCRendeASorrentinoAEfficacy and safety of off-label use of fondaparinux in the management of heparin-induced thrombocytopenia with thrombosis in an elderly womanJ Clin Pharmacol2013539999100223832870
  • GallelliLColosimoMTolottaGAProspective randomized double-blind trial of racecadotril compared with loperamide in elderly people with gastroenteritis living in nursing homesEur J Clin Pharmacol201066213714419902197
  • SerraRGallelliLBuffoneGDoxycycline speeds up healing of chronic venous ulcersInt Wound J201512217918423557025
  • deFranciscisSGallelliLBattagliaLCilostazol prevents foot ulcers in diabetic patients with peripheral vascular diseaseInt Wound J201512325025323672237
  • SerraRGallelliLContiAThe effects of sulodexide on both clinical and molecular parameters in patients with mixed arterial and venous ulcers of lower limbsDrug Des Devel Ther20148519527
  • AmatoBCompagnaRAmatoMGallelliLde FranciscisSSerraRAterofisiol® in carotid plaque evolutionDrug Des Devel Ther2015938773884
  • GallelliLFerreriGColosimoMRetrospective analysis of adverse drug reactions to bronchodilators observed in two pulmonary divisions of Catanzaro, ItalyPharmacol Res200347649349912742002
  • GallelliLFerreriGColosimoMAdverse drug reactions to antibiotics observed in two pulmonology divisions of Catanzaro, Italy: a six-year retrospective studyPharmacol Res200246539540012419643
  • GallelliLStaltariOPalleriaCDe SarroGFerraroMHepatotoxicity induced by methimazole in a previously healthy patientCurr Drug Saf20094320420619534646
  • GallelliLGalassoOFalconeDThe effects of nonsteroidal anti-inflammatory drugs on clinical outcomes, synovial fluid cytokine concentration and signal transduction pathways in knee osteoarthritis. A randomized open label trialOsteoarthritis Cartilage20132191400140823973155
  • LeeAYBauersachsRJanasMSCATCH InvestigatorsCATCH: a randomized clinical trial comparing long-term tinzaparin versus warfarin for treatment of acute venous thromboembolism in cancer patientsBMC Cancer20131328423764005
  • LeeAYLevineMNBakerRILow-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancerN Engl J Med2003349214615312853587
  • LeeAYKamphuisenPWMeyerGCATCH InvestigatorsTinzaparin vs warfarin for treatment of acute venous thromboembolism in patients with active cancer: a randomized clinical trialJAMA2015314767768626284719
  • ChoYKParkBWLeeMHHyonMSBangDWKimYJFatal massive and recurring pulmonary embolism followed by thrombocytopenia developed after heparin and warfarin treatment in a patient with metastatic breast cancer with an incidental large right atrialthrombusBlood Coagul Fibrinolysis201627221321526484641
  • WarkentinTEHeparin-induced thrombocytopeniaCurr Opin Crit Care201521657658526539932
  • TutwilerVMadeevaDAhnHSPlatelet transactivation by monocytes promotes the prothromboticstate in heparin-induced thrombocytopeniaBlood2016127446447226518435
  • WeiMWangCTLiDMSongXJProlonged use of fondaparinux for perioperative bridging: a case report of a patient with mechanical heart valve and heparin-induced thrombocytopeniaJ Clin Pharm Ther201540670270526573868
  • ChaudharyRKNepalCKhanalNPathakRGiriSBhattVRManagement and outcome of heparin-induced thrombocytopenia in pregnancy: a systematic reviewCardiovasc Hematol Agents Med Chem2015132929726695420
  • ShettyRSeddighzadehAParasuramanSVallurupalliNGGerhard-HermanMGoldhaberSZOnce-daily fondaparinux monotherapy without warfarin for long-term treatment of venous thromboembolismThromb Haemost20079861384138618064344
  • PesaventoRAmitranoMTrujillo-SantosJRIETE InvestigatorsFondaparinux in the initial and long-term treatment of venous throm-boembolismThromb Res2015135231131725543161